Ardagh Group S.A.

    Ardagh Group S.A.

    NNYSE:ARD
    24.75
    USD
    +0.63
    (+2.61%)
    Ardagh Group S.A.
    NYSE:ARD
    (New York Stock Exchange)

    Recent

    price

    24.75

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    No data availableFinancial data will appear here once available

    Capital Structure

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Working Capital

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Growth Rates

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Quarterly Revenue

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Quarterly Earnings Per Share

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Quarterly Dividends Per Share

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available
    Similar Companies
    Business

    Company News

    • Ardagh Metal Packaging S.A. - Third Quarter 2026 Results

    • Ardagh Metal Packaging S.A. Declares Quarterly Dividend

    • Ardagh Group Announces Sale of Trivium Packaging

    • Ardagh Metal Packaging: A Beverage Can Manufacturer That Needs To Improve Its Balance Sheet

    • SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of October 13, 2026 in Aardvark Therapeutics, Inc. Lawsuit - AARD

    • AARD UPCOMING DEADLINE: SueWallSt Alerts Aardvark Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm

    • AARD DEADLINE: SueWallSt Reminds Aardvark Therapeutics, Inc. Investors of Upcoming Securities Class Action Deadline

    • AARD Shareholder Alert: Aardvark Therapeutics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

    • Robbins LLP is Investigating Allegations that Aardvark Therapeutics, Inc. Misled Investors Regarding the Viability and Efficacy of its Lead Drug Candidate ARD-101

    • AARD Shareholder Alert: Aardvark Therapeutics, Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallSt

    • AARD DEADLINE: Levi & Korsinsky Reminds Aardvark Therapeutics, Inc. Investors of Upcoming Securities Class Action Deadline

    • AARD Deadline Alert: SueWallSt Reminds Aardvark Therapeutics, Inc. (AARD) Investors of Securities Class Action Deadline on October 13, 2026

    • Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 13, 2026 in Aardvark Therapeutics, Inc. Lawsuit - AARD

    • Are You Looking for a Top Momentum Pick? Why Ardagh Metal Packaging S.A.

    • Ardagh Metal Packaging Q2 Earnings Call Highlights

    • Ardagh Metal Packaging S.A. Declares Quarterly Dividend

    • Ardagh Metal Packaging S.A. - Second Quarter 2026 Results

    • Ardagh Metal Packaging: This 8% Yielder Still Looks Great

    • Ardagh Metal Packaging to participate in a fireside chat at the Wells Fargo 16th Annual Industrials & Materials Conference

    • Aardvark Therapeutics: Regulatory Uncertainty Clouds ARD-101 Path Forward